---
category: listing
circular_id: f90e2818fccebfbd
date: '2025-11-18'
description: NSE announces the listing and trading of 10.61 crore bonus equity shares
  of Thyrocare Technologies Limited effective December 02, 2025.
draft: false
guid: https://nsearchives.nseindia.com/content/circulars/CML71355.pdf
impact: medium
impact_ranking: medium
importance_ranking: medium
justification: Corporate action affecting existing shareholders through bonus issue;
  increases share capital but no immediate market disruption expected
pdf_url: https://nsearchives.nseindia.com/content/circulars/CML71355.pdf
processing:
  attempts: 1
  content_hash: 20d7e6327dc1a307
  processed_at: '2025-11-18T15:28:57.389997'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-11-18T00:00:00+05:30'
rss_url: https://nsearchives.nseindia.com/content/circulars/CML71355.pdf
severity: medium
source: nse
stocks:
- THYROCARE
tags:
- bonus-issue
- listing
- equity-shares
- thyrocare
- capital-market
title: Listing & Trading of Equity Shares pursuant to Bonus Issue of Thyrocare Technologies
  Limited
---

## Summary

The National Stock Exchange has approved the listing and trading of bonus equity shares issued by Thyrocare Technologies Limited. A total of 10,61,07,794 bonus shares will be admitted to trading on the Capital Market segment with effect from December 02, 2025. The shares will trade under the symbol THYROCARE with ISIN INE594H01019.

## Key Points

- Company: Thyrocare Technologies Limited
- Trading Symbol: THYROCARE
- ISIN: INE594H01019
- Total bonus shares: 10,61,07,794 equity shares
- Distinctive Number Range: 54012798 to 160120591
- Trading effective date: December 02, 2025
- Circular issued under Regulation 3.1.1 of NSE Capital Market Trading Regulations Part A

## Regulatory Changes

No regulatory changes. This is a standard listing notification for bonus shares pursuant to existing regulations.

## Compliance Requirements

- Members must use designated security codes for trading the bonus shares on the NSE system
- Securities will be identified only by their designated codes for trading purposes
- All trading participants must update their systems to reflect the increased share capital

## Important Dates

- **Circular Date**: November 18, 2025
- **Record Date**: November 28, 2025
- **Deemed Date of Allotment**: December 01, 2025
- **Trading Commencement Date**: December 02, 2025
- **Circular Effective Date**: December 02, 2025

## Impact Assessment

**Market Impact**: Medium - The bonus issue will increase the number of shares in circulation, potentially improving liquidity. Existing shareholders will receive additional shares proportionate to their holdings. The stock price will adjust proportionately to reflect the increased share count.

**Shareholder Impact**: Positive - Existing shareholders as of the record date will receive bonus shares, increasing their shareholding without any cash outlay. This makes the stock more accessible to retail investors through lower per-share pricing.

**Trading Impact**: The increased float may lead to improved trading volumes and liquidity in Thyrocare shares post-listing of bonus shares.